Related Experiment Video
Updated: Jun 26, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Emerging cell death in depression: Mechanisms and therapeutic implications
1Department of Nursing, Shengjing Hospital of China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, Liaoning Province 110004, China.
Summary
Major depressive disorder (MDD) research is exploring novel cell death pathways like ferroptosis and pyroptosis. Targeting these regulated cell death (RCD) mechanisms with natural products may offer new therapeutic strategies for MDD.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Major depressive disorder (MDD) is a prevalent psychiatric condition with complex, incompletely understood pathological mechanisms.
- Current treatments for MDD yield unsatisfactory outcomes for many patients, highlighting the need for novel therapeutic targets.
- Emerging regulated cell death (RCD) pathways, including ferroptosis and pyroptosis, are increasingly implicated in neurological and psychiatric disorders.
Purpose of the Study:
- To review the molecular mechanisms of emerging RCD pathways (ferroptosis, pyroptosis, cuproptosis).
- To explore the roles of ferroptosis and pyroptosis in the pathogenesis and treatment modulation of MDD.
- To examine natural products and traditional Chinese medicine as potential therapeutic agents targeting these RCD pathways in MDD.
Main Methods:
- Literature review focusing on preclinical studies.
- Analysis of molecular mechanisms underlying ferroptosis, pyroptosis, and cuproptosis.
- Synthesis of evidence linking RCD pathways to MDD pathogenesis and treatment.
Main Results:
- Ferroptosis and pyroptosis are closely involved in MDD pathogenesis.
- These RCD pathways are potential targets for therapeutic modulation in MDD.
- Natural products and traditional Chinese medicine show promise in targeting RCD pathways for MDD treatment, primarily based on preclinical data.
Conclusions:
- Emerging RCD pathways offer novel insights into MDD pathophysiology.
- Targeting ferroptosis and pyroptosis presents a promising avenue for developing new MDD therapies.
- Further research, particularly clinical studies, is needed to validate natural products and traditional Chinese medicine for MDD treatment via RCD modulation.
Related Concept Videos
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
01:05Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.